A detailed history of Hobbs Group Advisors, LLC transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Hobbs Group Advisors, LLC holds 18,653 shares of LIFE stock, worth $34,694. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,653
Holding current value
$34,694
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
N/A
18,653 New
18,653 $13.5 Million

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $53.2M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track Hobbs Group Advisors, LLC Portfolio

Follow Hobbs Group Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hobbs Group Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hobbs Group Advisors, LLC with notifications on news.